178 related articles for article (PubMed ID: 1279376)
1. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
Kaminski NE; Abood ME; Kessler FK; Martin BR; Schatz AR
Mol Pharmacol; 1992 Nov; 42(5):736-42. PubMed ID: 1279376
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
[TBL] [Abstract][Full Text] [Related]
4. Determination and characterization of a cannabinoid receptor in rat brain.
Devane WA; Dysarz FA; Johnson MR; Melvin LS; Howlett AC
Mol Pharmacol; 1988 Nov; 34(5):605-13. PubMed ID: 2848184
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction.
Chang MC; Berkery D; Schuel R; Laychock SG; Zimmerman AM; Zimmerman S; Schuel H
Mol Reprod Dev; 1993 Dec; 36(4):507-16. PubMed ID: 8305215
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.
Felder CC; Veluz JS; Williams HL; Briley EM; Matsuda LA
Mol Pharmacol; 1992 Nov; 42(5):838-45. PubMed ID: 1331766
[TBL] [Abstract][Full Text] [Related]
7. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
8. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor.
Howlett AC; Champion TM; Wilken GH; Mechoulam R
Neuropharmacology; 1990 Feb; 29(2):161-5. PubMed ID: 2158635
[TBL] [Abstract][Full Text] [Related]
9. CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells.
Zhou D; Song ZH
J Neurosci Res; 2001 Aug; 65(4):346-53. PubMed ID: 11494371
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
[TBL] [Abstract][Full Text] [Related]
11. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.
Lynn AB; Herkenham M
J Pharmacol Exp Ther; 1994 Mar; 268(3):1612-23. PubMed ID: 8138973
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid ligand-receptor signaling in the mouse uterus.
Das SK; Paria BC; Chakraborty I; Dey SK
Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a cannabinoid receptor in immunomodulation by cannabinoid compounds.
Kaminski NE
Adv Exp Med Biol; 1993; 335():115-20. PubMed ID: 8237584
[No Abstract] [Full Text] [Related]
14. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
Buckley NE; McCoy KL; Mezey E; Bonner T; Zimmer A; Felder CC; Glass M; Zimmer A
Eur J Pharmacol; 2000 May; 396(2-3):141-9. PubMed ID: 10822068
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol.
Qureshi J; Saady M; Cardounel A; Kalimi M
Mol Cell Biochem; 1998 Apr; 181(1-2):21-7. PubMed ID: 9562238
[TBL] [Abstract][Full Text] [Related]
16. Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.
Massi P; Patrini G; Rubino T; Fuzio D; Parolaro D
Pharmacol Biochem Behav; 1997 Sep; 58(1):73-8. PubMed ID: 9264073
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
[TBL] [Abstract][Full Text] [Related]
18. O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties.
Pertwee RG; Gibson TM; Stevenson LA; Ross RA; Banner WK; Saha B; Razdan RK; Martin BR
Br J Pharmacol; 2000 Apr; 129(8):1577-84. PubMed ID: 10780961
[TBL] [Abstract][Full Text] [Related]
19. Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.
Bosier B; Muccioli GG; Mertens B; Sarre S; Michotte Y; Lambert DM; Hermans E
Neuropharmacology; 2012 Jun; 62(7):2328-36. PubMed ID: 22365976
[TBL] [Abstract][Full Text] [Related]
20. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.
Bosier B; Hermans E; Lambert DM
Biochem Pharmacol; 2009 Jan; 77(2):216-27. PubMed ID: 18992715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
